Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma
PLoS ONE2018Vol. 13(8), pp. e0200204–e0200204
Citations Over TimeTop 11% of 2018 papers
Abstract
Patients with SBA who received adjuvant therapy after surgery did not receive a significant survival benefit. Adjuvant therapy may be more useful in advanced cancer or metastatic patients.
Related Papers
- Long-term outcomes of neoadjuvant treatment of HER2-positive breast cancer.(2016)
- 食道がんにおける「Neoadjuvant therapy後の切除」は「Conversion therapy」か? (特集 Conversion Therapy (Adjuvant Surgery) : Stage IV症例に対する治療の奏効に伴う切除) -- (各がん腫におけるConversion therapyとNeoadjuvant therapy)(2015)
- 大腸がんにおける「Conversion therapy」は「Neoadjuvant therapy後の切除」か? (特集 Conversion Therapy (Adjuvant Surgery) : Stage IV症例に対する治療の奏効に伴う切除) -- (各がん腫におけるConversion therapyとNeoadjuvant therapy)(2015)
- → 25. THE ROLE OF ADJUVANT THERAPY FOR PATIENTS WITH ESOPHAGEAL ADENOCARCINOMA UNDERGOING NEOADJUVANT THERAPY AND ESOPHAGECTOMY(2023)